Volume | 5,063 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Sunshine Biopharma Inc | SBFM | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.33 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
23 | 5,063 | - | 0.2811 - 64.50 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
03:45:31 | formt | 129 | US$ 0.3166 | USD |
Sunshine Biopharma Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
8.47M | 25.68M | - | 24.09M | -4.51M | -0.18 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Sunshine Biopharma News
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SBFM Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.39 | 0.435 | 0.2811 | 0.3709307 | 7,502,483 | -0.0734 | -18.82% |
1 Month | 0.993 | 1.05 | 0.2811 | 0.5267038 | 3,774,830 | -0.6764 | -68.12% |
3 Months | 6.20 | 13.25 | 0.2811 | 6.97 | 13,199,780 | -5.88 | -94.89% |
6 Months | 24.00 | 30.40 | 0.2811 | 7.43 | 13,803,772 | -23.68 | -98.68% |
1 Year | 53.00 | 64.50 | 0.2811 | 7.80 | 6,955,026 | -52.68 | -99.40% |
3 Years | 275.00 | 987.00 | 0.2811 | 162.56 | 4,554,639 | -274.68 | -99.88% |
5 Years | 275.00 | 987.00 | 0.2811 | 162.56 | 4,554,639 | -274.68 | -99.88% |
Sunshine Biopharma Description
Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5). |